Opgen Inc (CFOR) — 10-Q Filings
All 10-Q filings from Opgen Inc. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
OpGen Pivots to FinTech, Reports $4M Revenue from Listing Services
— Nov 19, 2025 Risk: high
OPGEN INC (CFOR) reported a significant strategic shift from precision medicine to financial services and technology, marked by the deconsolidation of its infec -
OPGEN Pivots to Financial Services, Posts $3.1M Net Income
— Oct 31, 2025 Risk: high
OPGEN INC (CFOR) reported a significant strategic pivot and a dramatic improvement in financial performance for the six months ended June 30, 2025. The company -
OPGEN Pivots to FinTech, Faces Nasdaq Delisting Amidst Revenue Collapse
— Oct 1, 2025 Risk: high
OPGEN INC (OPGN) reported a significant shift in its business model and financial performance for the three months ended March 31, 2025. The company recorded ze -
Opgen Inc. Files Q3 2024 10-Q Report
— Nov 15, 2024 Risk: medium
Opgen Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter of 20 -
OpGen Inc. Files Q1 2024 10-Q
— Jul 8, 2024 Risk: low
OpGen Inc. filed its 10-Q for the period ending March 31, 2024. The filing details financial performance for the first quarter of 2024, including revenue from p
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX